Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study
Titel:
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study
Auteur:
Martín, Miguel Zielinski, Christoph Ruiz-Borrego, Manuel Carrasco, Eva Ciruelos, Eva M. Muñoz, Montserrat Bermejo, Begoña Margelí, Mireia Csöszi, Tibor Antón, Antonio Turner, Nicholas Casas, María I. Morales, Serafín Alba, Emilio Calvo, Lourdes de la Haba-Rodríguez, Juan Ramos, Manuel Murillo, Laura Santaballa, Ana Alonso-Romero, José L. Sánchez-Rovira, Pedro Corsaro, Massimo Huang, Xin Thallinger, Christiane Kahan, Zsuzsanna Gil-Gil, Miguel